Supakarn Chamni
Impact in
- Biotechnology top 5%
- Marine Sponges and Natural Products
- Cancer Research top 10%
- Synthesis and Biological Activity
Papers in
-
- Synthesis and Biological Activity 21
- Pharmacology 19
- Microbial Natural Products and Biosynthesis 15
- Co-authors
- Pithi Chanvorachote (21 shared papers)Khanit Suwanborirux (19 shared papers)Naoki Saito (12 shared papers)Thanyada Rungrotmongkol (13 shared papers)Wanchai De‐Eknamkul (7 shared papers)Panupong Mahalapbutr (3 shared papers)Chatchai Chaotham (7 shared papers)Chonnikant Visuthranukul (4 shared papers)
- Journals
- Marine Drugs (6 papers)Scientific Reports (5 papers)Journal of Natural Products (4 papers)Molecules (4 papers)Anticancer Research (4 papers)
- Partner nations
- ThailandJapanUnited States
In The Last Decade
Supakarn Chamni
53 papers receiving 768 citations
Peers
Comparison fields: 5 of 92
- Biotechnology 162
- Cancer Research 207
- Pharmacology 203
- Toxicology 30
- Pharmaceutical Science 45
Countries citing papers authored by Supakarn Chamni
This map shows the geographic impact of Supakarn Chamni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Supakarn Chamni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Supakarn Chamni more than expected).
Fields of papers citing papers by Supakarn Chamni
This network shows the impact of papers produced by Supakarn Chamni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Supakarn Chamni. The network helps show where Supakarn Chamni may publish in the future.
Co-authors
The 25 scholars most cited alongside Supakarn Chamni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 63 | |
| 2 | 2020 | 38 | |
| 3 | 2018 | 31 | |
| 4 | Renieramycin M Sensitizes Anoikis-resistant H460 Lung Cancer Cells to Anoikis. | 2016 | 28 |
| 5 | 2019 | 27 | |
| 6 | 2024 | 26 | |
| 7 | 2022 | 26 | |
| 8 | 2017 | 25 | |
| 9 | 2019 | 24 | |
| 10 | 2023 | 23 | |
| 11 | 2016 | 23 | |
| 12 | 2019 | 23 | |
| 13 | 2019 | 22 | |
| 14 | 2018 | 21 | |
| 15 | 2013 | 21 | |
| 16 | 2022 | 21 | |
| 17 | 2014 | 20 | |
| 18 | 2017 | 19 | |
| 19 | 2008 | 17 | |
| 20 | 2021 | 16 |
About Supakarn Chamni
Supakarn Chamni is a scholar working on Cancer Research, Pharmacology, Biotechnology, Organic Chemistry and Molecular Biology, having authored 56 papers that have together received 771 indexed citations. Recurring topics across this work include Synthesis and Biological Activity (21 papers), Marine Sponges and Natural Products (16 papers), Microbial Natural Products and Biosynthesis (15 papers), Carbohydrate Chemistry and Synthesis (4 papers), Bioactive Compounds and Antitumor Agents (4 papers), Medicinal Plants and Neuroprotection (4 papers), Chemical synthesis and alkaloids (3 papers) and Advanced Drug Delivery Systems (3 papers). The work is most often cited by research in Biotechnology (162 citations), Cancer Research (207 citations), Pharmacology (203 citations), Toxicology (30 citations) and Pharmaceutical Science (45 citations). Supakarn Chamni has collaborated with scholars based in Thailand, Japan and United States. Frequent co-authors include Pithi Chanvorachote, Khanit Suwanborirux, Naoki Saito, Thanyada Rungrotmongkol, Wanchai De‐Eknamkul, Panupong Mahalapbutr, Chatchai Chaotham, Chonnikant Visuthranukul, Sirinuch Chomtho and Daniel Romo. Their work appears in journals such as Marine Drugs, Scientific Reports, Journal of Natural Products, Molecules and Anticancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.